Patents by Inventor Brad Lackford

Brad Lackford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides
    Patent number: 9970068
    Abstract: The invention relates to improved methods and compositions for the nucleic acid amplification of one or multiple variants (strains) of Human Immunodeficiency Virus (HIV) present in a sample, and preferably in a sample from a pathogen infected individual. In particular, novel primers, methods and kits for the amplification of one or more species of HIV Rev, Gag and Nef nucleic acids are provided. The amplified HIV nucleic acid can be used to identify and/or quantitate HIV variants present in a sample. Nucleic acids produced by the methods of the invention or the proteins encoded thereby can also be used directly as vaccines or to transfect/load antigen presenting cells. The loaded antigen presenting cells can be used as a vaccine for the treatment or prevention of HIV infection.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: May 15, 2018
    Assignee: Argos Therapeutics, Inc.
    Inventors: Irina Tcherepanova, Aijing Starr, Brad Lackford
  • Primers and Probes for the Amplification and Detection of HIV GAG, REV and NEF Polynucleotides
    Publication number: 20120231509
    Abstract: The invention relates to improved methods and compositions for the nucleic acid amplification of one or multiple variants (strains) of Human Immunodeficiency Virus (HIV) present in a sample, and preferably in a sample from a pathogen infected individual. In particular, novel primers, methods and kits for the amplification of one or more species of HIV Rev, Gag and Nef nucleic acids are provided. The amplified HIV nucleic acid can be used to identify and/or quantitate HIV variants present in a sample. Nucleic acids produced by the methods of the invention or the proteins encoded thereby can also be used directly as vaccines or to transfect/load antigen presenting cells. The loaded antigen presenting cells can be used as a vaccine for the treatment or prevention of HIV infection.
    Type: Application
    Filed: May 24, 2012
    Publication date: September 13, 2012
    Applicant: ARGOS THERAPEUTICS, INC.
    Inventors: Irina Tcherepanova, Aijing Starr, Brad Lackford
  • Primers and probes for the amplification and detection of HIV Gag, Rev and Nef polynucleotides
    Patent number: 8221981
    Abstract: The invention relates to improved methods and compositions for the nucleic acid amplification of one or multiple variants (strains) of Human Immunodeficiency Virus (HIV) present in a sample, and preferably in a sample from a pathogen infected individual. In particular, novel primers, methods and kits for the amplification of one or more species of HIV Rev, Gag and Nef nucleic acids are provided. The amplified HIV nucleic acid can be used to identify and/or quantitate HIV variants present in a sample. Nucleic acids produced by the methods of the invention or the proteins encoded thereby can also be used directly as vaccines or to transfect/load antigen presenting cells. The loaded antigen presenting cells can be used as a vaccine for the treatment or prevention of HIV infection.
    Type: Grant
    Filed: July 30, 2008
    Date of Patent: July 17, 2012
    Assignee: Argos Therapeutics, Inc.
    Inventors: Irina Tcherepanova, Aijing Starr, Brad Lackford